Figure - PMC

Skip to main content

View full-text article in PMC

. Author manuscript; available in PMC: 2020 Dec 29.

Published in final edited form as: Anticancer Res. 2018 Jul;38(7):3843–3852. doi: 10.21873/anticanres.12668

Figure 2. — Western blot analyses of benign oral mucosae and OSCC for the CBS (A), CSE (B), 3-MST (C), Nampt (D), mitoNEET (E), phospho-Stat3 (F), hTERT (G), MAPK (H), SQOR (I) and ATM (J) proteins. ***p<0.001. SQOR and ATM (2I and 2J) did not have statistically significant differences between benign oral epithelium and OSCC.

Figure 2. — Western blot analyses of benign oral mucosae and OSCC for the CBS (A), CSE (B), 3-MST (C), Nampt (D), mitoNEET (E), phospho-Stat3 (F), hTERT (G), MAPK (H), SQOR (I) and ATM (J) proteins. ***p<0.001. SQOR and ATM (2I and 2J) did not have statistically significant differences between benign oral epithelium and OSCC.